Eli Lilly Corp. buy Argus
Start price
05.09.23
/
50%
€520.50
Target price
05.09.24
€578.15
Performance (%)
57.33%
End price
06.09.24
€818.90
Summary
This prediction ended on 06.09.24 with a price of €818.90. With a performance of 57.33% the BUY prediction by Argus was a big success. Argus has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €4.63 are taken into consideration when calculating the performance. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -1.365% | -1.365% | 61.279% |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Argus for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Argus from $470.00 to $620.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Argus gewählte maximale Laufzeit wurde überschritten